||2 doses, three weeks apart
||Pain/tenderness/redness/swelling at injection site, fatigue, muscle pain, headache, joine pain, nausea, fever
||Approved for ages 12 and up under Emergency Use Authorization
|Johnson & Johnson/Janssen
||1 dose; booster shot after 2 months
||Pain, redness and swelling at the injection site; headache, feeling very tired, muscle aches, nausea, fever.
||Approved for limited use for certain individuals under Emergency Use Authorization.
|2 doses, 21 days apart, with a 3rd dose recommended for those who are immunocompromised and booster shot for ages 12 and up after five months
||Injection site pain, tiredness, headaches, muscle pain, chills, joint pain, fever, injection site soreness and redness, nausea, swollen lymph nodes, feeling unwell.
||Full FDA approval for ages 16 and over.
Emergency Use Authorization for those ages 6 months-15 years.
|2 doses, 28 days apart, with a 3rd dose recommended for those who are immunocompromised and booster shot for all adults after 6 months
||Pain and swelling in lymph nodes in same arm as injection, fatigue, headache, muscle pain, joint pain, chills, nausea and vomiting, fever.
||Full FDA approval for ages 18 and over.
Emergency Use Authorization for those ages 6 months-17 years.